Physician profile
Jay D Pal
NPI 1396936548
$79,458.64
in general payments reported to CMS, 2019-2025
11 companies · $925 in 2025
The $925 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39K · 2020: $29K · 2021: $5,167 · 2022: $3,186 · 2023: $972 · 2024: $1,863 · 2025: $925.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,264 · Travel and Lodging: $497.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,263.72 |
| Travel and Lodging | $496.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $67,179.55 | 2019-2020 | |
| Medtronic, INC. | $5,277.58 | 2021-2025 | Avalus |
| Abbott Laboratories | $3,933.09 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, 2nd Gen Centrimag Primary Console, Epic |
| Abiomed | $1,190.94 | 2021-2024 | Impella |
| Paragonix Technologies, INC. | $516.82 | 2024-2025 | Sherpapak, Liverguard, Pancreaspak |
| Intuitive Surgical, INC. | $496.64 | 2024 | |
| Xvivo Perfusion INC. | $346.06 | 2024 | Xvivo Perfusion System (Xps) |
| Livanova USA, INC. | $236.16 | 2022-2023 | Lifesparc |
| Edwards Lifesciences Corporation | $176.99 | 2021-2024 | |
| Boston Scientific Corporation | $104.81 | 2024 | Avvigo Guidance System |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Pal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.